Brian brings over 30 years of leadership and innovation to modern healthcare. Throughout his distinguished career, he has driven growth across senior sales and business development roles, anchored by deep expertise as a Founder and Chairman in the healthcare SaaS sector. An active angel investor, Brian is also a co-inventor on multiple diagnostic patent applications.
Devin delivers over 18 years of commercial and operational leadership to the team. He previously served as Vice President of Sales for a prominent nationwide infrastructure services firm valued at over $250 million, driving large-scale go-to-market strategies. His executive background also includes co-founding a successful healthcare SaaS platform alongside multiple senior advisory roles.
Anthony is an elite MedTech executive and global market strategist with a track record of driving $500M+ in revenue expansion. His corporate leadership spans two successful IPOs and eight strategic acquisitions totaling $3.75 billion. Previously, he launched Qualcomm’s healthcare division, guided Quidel through unprecedented global pandemic growth, and pioneered Cardinal Health’s foundational patient safety programming.
Christina is a seasoned biotechnology executive with over 25 years of experience driving commercialization across the pharmaceutical and biotech sectors. As CEO of Rapid Commercialization Partners (RCP), she accelerates launch readiness and market access for clinical-stage companies. Her background includes senior leadership roles at Alexion, Agile Therapeutics, and PTC Therapeutics.
Leesa brings decades of clinical leadership to the team, currently serving as Chief Clinical Officer at RenovoRx. She previously led global clinical trials and business strategies at Evotec and Otsuka Pharmaceutical. Earlier in her career, she managed major clinical portfolios for top-tier contract research organizations including IQVIA, PPD, and Omnicare.
Mark and Norma are mission-driven entrepreneurs and venture investors dedicated to advancing healthcare breakthroughs. Personally motivated by the loss of their parents to sepsis, they actively back life-saving diagnostic innovations. They are the founders of Venture Starters, a dynamic startup ecosystem that has mentored and hosted over 4,500 founder pitches targeting global challenges.
Ghazi brings over 25 years of medical device expertise across regulatory affairs, quality systems, and clinical development. He has successfully spearheaded global product registration strategies across multiple complex international markets. His extensive leadership background includes executive roles at IdentifySensors, Lucira Health, Thermo Fisher Scientific, Becton Dickinson, and Orchid Orthopedic Solutions.
Dr. Pitt is a Professor of Chemical Engineering at Brigham Young University and a leading expert in microfluidics. With over 235 publications and 8 patents, his NIH-funded research centers on engineering rapid blood diagnostic mechanisms that isolate pathogens using centrifugal micro-discs, directly supporting our mission to eliminate the wait for sepsis diagnostics.
Dr. Hill is an Associate Professor at Brigham Young University and holds a Ph.D. in Genetics and Development from Columbia University. He specializes in molecular genetics, high-throughput sequencing, and bioinformatics. His work bridges the gap between molecular biology and diagnostics engineering. He has experience with blood-based liquid biopsies and cell-free DNA analysis from blood samples.